Hepatorenal syndrome: a dreaded complication of end-stage liver disease. - Wikidata - wikimedia - TriplyDB

Hepatorenal syndrome: a dreaded complication of end-stage liver disease.

Hepatorenal syndrome: a dreaded complication of end-stage liver disease.

http://www.wikidata.org/entity/Q36018527

about

Effect of heme oxygenase-1 on renal function in rats with liver cirrhosis.Therapy insight: Management of hepatorenal syndrome.Use of mesenchymal stem cells to treat liver fibrosis: current situation and future prospects.Acute renal dysfunction in liver diseases Recent advances in the management of hepato-renal syndrome (HRS).Clinical use of albumin in hepatology.Gastrointestinal dysfunction in liver cirrhosis The use of nanoparticles to deliver nitric oxide to hepatic stellate cells for treating liver fibrosis and portal hypertension.Strain of experimental animals and modulation of nitric oxide pathway: their influence on development of renal failure in an experimental model of hepatorenal syndrome.Bile duct ligation in rats: a reliable model of hepatorenal syndrome?Comparison of bone marrow-vs. adipose tissue-derived mesenchymal stem cells for attenuating liver fibrosis.Protective Effects of the Third Generation Vasodilatory Βeta - Blocker Nebivolol against D-Galactosamine - Induced Hepatorenal Syndrome in Rats.Serum sodium and hydration status predict transplant-free survival independent of MELD score in patients with cirrhosis.

P2860

Q34497439-7AA5F76F-3BB6-47C7-B5D4-0ADE8AAE6C61 Q34533221-DD0D0764-9297-4627-ACEC-629932FC0828 Q34985947-D3BF504B-B3A3-4278-9C54-0DBC7198CCED Q36975923-C212C237-1978-4783-A0D3-2F0910CD9134 Q37088317-6602BD27-9CED-44B4-98EE-51D4D1D3071E Q37655017-398941F2-0748-4F31-AB41-DA2A26B804F4 Q38263849-A31BF46E-46E4-4987-BFE8-169BBF1333B6 Q38914065-742E9058-CA05-4E29-8D4D-509CF16BC722 Q42214939-9948D613-1567-4A68-B7C3-2B10F4A0AD74 Q43166084-46687946-B154-473B-8437-DDBFFC81A53E Q47143390-68C1F467-2F66-4CBA-9F05-F1955CF17E40 Q49362450-02161520-114A-4F28-9625-314C93F23AFF Q51753856-2DE212D2-F4FD-49CA-AF97-0ABD0681EBDE

P2860

Hepatorenal syndrome: a dreaded complication of end-stage liver disease.

http://www.wikidata.org/entity/Q36018527

description

2005 nî lūn-bûn

@nan

2005年の論文

@ja

2005年論文

@yue

2005年論文

@zh-hant

2005年論文

@zh-hk

2005年論文

@zh-mo

2005年論文

@zh-tw

2005年论文

@wuu

2005年论文

@zh

2005年论文

@zh-cn

name

Hepatorenal syndrome: a dreaded complication of end-stage liver disease.

@ast

Hepatorenal syndrome: a dreaded complication of end-stage liver disease.

@en

type

label

Hepatorenal syndrome: a dreaded complication of end-stage liver disease.

@ast

Hepatorenal syndrome: a dreaded complication of end-stage liver disease.

@en

prefLabel

Hepatorenal syndrome: a dreaded complication of end-stage liver disease.

@ast

Hepatorenal syndrome: a dreaded complication of end-stage liver disease.

@en

P1433

Q36018527-6DC8BB89-C782-48C9-8547-E9A1DB70EB82

P1476

Q36018527-23BE790A-055A-44CF-869D-17458FACBFC6

P2093

Q36018527-16090F0E-F99B-4036-B1E4-D6EE070F549B

P2860

Q36018527-0774B9C9-1DFE-4FE2-B339-257559717F24

Q36018527-088B6C30-1758-4FAE-81F4-67B2CF2E6767

Q36018527-160E46AF-C73C-47FF-8F3F-3915E0D69E9D

Q36018527-45ABE26D-E0C0-4505-A44F-E4AA56B660A0

Q36018527-4BFCE45A-FBF7-41EA-9146-5FC340CA82FF

Q36018527-51362C41-CA29-4246-9993-46D838D78E0D

Q36018527-525BDE05-D399-464B-BEA4-5C2FBE257DE4

Q36018527-79B5CBDC-6459-4B8C-8786-47BF63104CEE

Q36018527-79EDDE86-85C0-4710-A26A-F7A1232D9587

Q36018527-83C4DF7E-55F9-40C5-9E03-EFA0B5AFD0C2

P304

Q36018527-428444D2-34A3-40E5-8F96-7833FD1C63E5

P31

Q36018527-99F7CF05-68E9-4FCD-BA1B-1C6448B94DA4

P356

Q36018527-0106BD6F-B148-4DFC-ABE9-E361F39E36E7

P407

Q36018527-05DB12A2-5146-46A3-BEBF-9C74187F77FA

P433

Q36018527-1CB4F457-3CD4-423D-B2E7-7543BF7AF8F4

P478

Q36018527-9D65A65E-304A-40BC-9A5B-1857F092C4FB

P50

Q36018527-3CDBC394-66BB-4D1B-9166-23F10383008E

P577

Q36018527-DC9BF5CD-6709-451A-A0D5-D1004DEBB5C0

P5875

Q36018527-AFC97F10-BFA5-4743-BA86-8277930763C9

P698

Q36018527-333BB2F8-A1FD-4705-B834-C9B47E0E3E96

P356

J.1572-0241.2005.40952.X

P1433

The American Journal of Gastroenterology

P1476

Hepatorenal syndrome: a dreaded complication of end-stage liver disease

@en

P2093

Andrés Cárdenas

http://www.w3.org/2001/XMLSchema#string

P2860

A model to predict survival in patients with end-stage liver disease

Reversal of type 1 hepatorenal syndrome with the administration of midodrine and octreotide.

Effect of intravenous albumin on renal impairment and mortality in patients with cirrhosis and spontaneous bacterial peritonitis.

Long-term therapy and retreatment of hepatorenal syndrome type 1 with ornipressin and dopamine.

Terlipressin plus albumin infusion: an effective and safe therapy of hepatorenal syndrome.

Terlipressin therapy with and without albumin for patients with hepatorenal syndrome: results of a prospective, nonrandomized study.

Management of cirrhosis and ascites.

Midodrine, octreotide, albumin, and TIPS in selected patients with cirrhosis and type 1 hepatorenal syndrome.

Definition and diagnostic criteria of refractory ascites and hepatorenal syndrome in cirrhosis. International Ascites Club.

Reversibility of hepatorenal syndrome by prolonged administration of ornipressin and plasma volume expansion.

P304

460-467

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/J.1572-0241.2005.40952.X

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

100

http://www.w3.org/2001/XMLSchema#string

P50

Andres Cardenas

P577

2005-02-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

8063244

http://www.w3.org/2001/XMLSchema#string

P698

15667508

http://www.w3.org/2001/XMLSchema#string